Collectively, our findings reveal BMAL1 as a critical negative regulator of post-MI myocardial fibrosis by inhibiting the TGF-β1/SMAD3 pathway mediated by SMAD7. The gene discussed is TGFB1; the disease is Myocardial fibrosis.